Replimune
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Replimune and other ETFs, options, and stocks.About REPL
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer.
REPL Key Statistics
Stock Snapshot
Replimune(REPL) stock is priced at $8.50, giving the company a market capitalization of 650.21M. It carries a P/E multiple of -2.46.
On 2025-11-09, Replimune(REPL) stock traded between a low of $7.99 and a high of $8.64. Shares are currently priced at $8.50, which is +6.4% above the low and -1.6% below the high.
Replimune(REPL) shares are trading with a volume of 2.25M, against a daily average of 3.08M.
During the past year, Replimune(REPL) stock moved between $2.68 at its lowest and $17.00 at its peak.
During the past year, Replimune(REPL) stock moved between $2.68 at its lowest and $17.00 at its peak.
REPL News
Replimune Group ( (REPL) ) has released its Q2 earnings. Here is a breakdown of the information Replimune Group presented to its investors. Meet Your ETF AI An...
Analyst Robert Burns from H.C. Wainwright reiterated a Buy rating on Replimune Group and keeping the price target at $12.00. Meet Your ETF AI Analyst Discover h...
“After a collaborative dialogue and productive engagement with the FDA we are encouraged by the acceptance of our BLA resubmission for RP1 in combination with n...